Ali Asgary

InstitutionYork University
AddressToronto
Ontario
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in December 2020 and July 2021
    All Publications
    Bar chart showing 12 publications over 7 distinct years, with a maximum of 4 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mellado B, Wu J, Kong JD, Bragazzi NL, Asgary A, Kawonga M, Choma N, Hayasi K, Lieberman B, Mathaha T, Mbada M, Ruan X, Stevenson F, Orbinski J. Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa. Int J Environ Res Public Health. 2021 07 26; 18(15). PMID: 34360183.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Stevenson F, Hayasi K, Bragazzi NL, Kong JD, Asgary A, Lieberman B, Ruan X, Mathaha T, Dahbi SE, Choma J, Kawonga M, Mbada M, Tripathi N, Orbinski J, Mellado B, Wu J. Development of an Early Alert System for an Additional Wave of COVID-19 Cases Using a Recurrent Neural Network with Long Short-Term Memory. Int J Environ Res Public Health. 2021 07 09; 18(14). PMID: 34299827.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Asgary A, Cojocaru MG, Najafabadi MM, Wu J. Simulating preventative testing of SARS-CoV-2 in schools: policy implications. BMC Public Health. 2021 01 12; 21(1):125. PMID: 33430832.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    4. Asgary A, Valtchev SZ, Chen M, Najafabadi MM, Wu J. Artificial Intelligence Model of Drive-Through Vaccination Simulation. Int J Environ Res Public Health. 2020 12 31; 18(1). PMID: 33396526.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    5. McCarthy Z, Xiao Y, Scarabel F, Tang B, Bragazzi NL, Nah K, Heffernan JM, Asgary A, Murty VK, Ogden NH, Wu J. Quantifying the shift in social contact patterns in response to non-pharmaceutical interventions. J Math Ind. 2020; 10(1):28. PMID: 33282625.
      Citations: 3     
    6. Asgary A, Najafabadi MM, Karsseboom R, Wu J. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic. Healthcare (Basel). 2020 Nov 09; 8(4). PMID: 33182336.
      Citations: 9     
    7. Tang B, Scarabel F, Bragazzi NL, McCarthy Z, Glazer M, Xiao Y, Heffernan JM, Asgary A, Ogden NH, Wu J. De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study. Biology (Basel). 2020 May 16; 9(5). PMID: 32429450.
      Citations: 14